OpenAI公布GPT-Rosalind-6受限访问规则
OpenAI的GPT-Rosalind-6系统卡附录称,这款生命科学模型仅向获批客户开放。开放前,OpenAI会审查申请方是否具备正当的生命科学或相关使命、可信的用例、恰当的研究与运营治理,以及安全控制模型访问的能力。非政府申请方还需接受商业验证与合规筛查;政府申请方则可通过可信访问渠道,参与获批的生物安全、生物防护、公共卫生准备和生物防御项目。GPT-Rosalind-6沿用GPT-Rosalind-5.5已有的访问要求,并未扩大此前公告所涉的资格范围,例如Rosalind Academic Plan。获批的企业客户必须仅向有正当需要的授权用户开放模型,采取最小权限和内部人员风险控制措施,并在模型输出用于实验、出版物或重要决策前进行合格人工复核。
该附录明确了谁可以访问GPT-Rosalind-6,以及获批企业客户必须遵守的筛查、访问控制和人工复核保障措施。
GPT-Rosalind-6 is available only to approved customers. Before granting access, OpenAI reviews whether the applicant has a legitimate life sciences or related mission, a credible use case, appropriate research and operational governance, and the ability to safely control access to the model.
GPT-Rosalind-6 uses the access requirements already applied to GPT-Rosalind-5.5, including the policy updates introduced since its launch. This release does not broaden eligibility beyond prior announcements, such as the Rosalind Academic Plan.
For non-government applicants, OpenAI also employs business verification and compliance-screening checks. These checks help confirm applicant authenticity and reduce the risk of access by fraudulent, insufficiently attributable, or otherwise unsuitable actors. These checks supplement OpenAI’s broader review of the applicant’s proposed use case, safety posture, and access scope.
For government applicants, OpenAI maintains a trusted-access pathway for select government entities working on approved biosecurity, biosafety, public-health preparedness, and biodefense use cases.
Approved enterprise customers must limit GPT-Rosalind-6 access to authorized users with a legitimate need and apply least-privilege access controls, appropriate onboarding, and insider risk controls to their users. Customers must apply qualified human review before model outputs inform experiments, publications, or consequential decisions.
#OpenAI#GPT-Rosalind-6#GPT-Rosalind-5.5#Rosalind Academic Plan